North Crest Asset Manangement, LLC Biogen Inc. Transaction History

North Crest Asset Manangement, LLC

$4 Billion
Q3 2025

A detailed history of North Crest Asset Manangement, LLC transactions in Biogen Inc. stock. As of the latest transaction made, North Crest Asset Manangement, LLC holds 32,636 shares of BIIB stock, worth $5.47 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

32,636

Previous 32,669 0.1%

Holding current value

$5.47 Million

Previous $4.1 Million 11.43%

% of portfolio

0.11%

Previous 0.12%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 29, 2025	SELL	$122.68 - $148.84 $4,048 - $4,911	-33 Reduced 0.1%	32,636 $4.57 Million
Q2 2025 Jul 10, 2025	SELL	$113.38 - $135.49 $211,226 - $252,417	-1,863 Reduced 5.39%	32,669 $4.1 Million
Q1 2025 Apr 16, 2025	BUY	$133.43 - $153.27 $283,672 - $325,852	2,126 Added 6.56%	34,532 $4.73 Million
Q4 2024 Mar 17, 2025	BUY	$146.47 - $191.55 $80,265 - $104,969	548 Added 1.72%	32,406 $4.96 Million
Q3 2024 Oct 23, 2024	BUY	$189.07 - $236.8 $72,981 - $91,404	386 Added 1.23%	31,858 $6.18 Million

Q2 2024 Jul 16, 2024	BUY	$190.52 - $236.72 $7,239 - $8,995	38 Added 0.12%	31,472 $7.3 Million
Q1 2024 Apr 15, 2024	BUY	$212.02 - $267.71 $77,387 - $97,714	365 Added 1.17%	31,434 $6.78 Million
Q4 2023 Jan 30, 2024	SELL	$222.59 - $267.94 $207,008 - $249,184	-930 Reduced 2.91%	31,069 $8.04 Million
Q3 2023 Nov 13, 2023	BUY	$253.3 - $285.89 $154,006 - $173,821	608 Added 1.94%	31,999 $8.22 Million
Q2 2023 Jul 21, 2023	SELL	$275.25 - $318.06 $42,663 - $49,299	-155 Reduced 0.49%	31,391 $8.94 Million
Q1 2023 Apr 25, 2023	BUY	$256.56 - $292.34 $8.09 Million - $9.22 Million	31,546 New	31,546 $8.77 Million
Q4 2022 Feb 01, 2023	SELL	$252.44 - $306.72 $234,264 - $284,636	-928 Reduced 2.85%	31,623 $8.76 Million
Q3 2022 Oct 17, 2022	SELL	$194.69 - $268.46 $22,778 - $31,409	-117 Reduced 0.36%	32,551 $8.69 Million
Q2 2022 Jul 18, 2022	BUY	$187.54 - $223.02 $93,582 - $111,286	499 Added 1.55%	32,668 $6.66 Million
Q1 2022 Apr 18, 2022	BUY	$193.77 - $244.14 $1.2 Million - $1.51 Million	6,196 Added 23.86%	32,169 $6.78 Million
Q4 2021 Feb 09, 2022	BUY	$223.92 - $287.77 $5.82 Million - $7.47 Million	25,973 New	25,973 $6.23 Million

Others Institutions Holding BIIB

# of Institutions

1,075

Shares Held

131M

Call Options Held

3.77M

Put Options Held

2.31M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $24.1B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of North Crest Asset Manangement, LLC, based on Form 13F filings with the SEC.

News

Stay updated on North Crest Asset Manangement, LLC with notifications on news.

Account

North Crest Asset Manangement, LLC Biogen Inc. Transaction History